Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry

Autor:	Daniel M. Shindler, John B. Kostis, Salim Yusuf, Miguel A. Quinones, Bertram Pitt, Dawn Stewart, Tamara Pinkett, Jalal K. Ghali, Alan C. Wilson, null The SOLVD Investigators
Rok vydání:	1996
Předmět:	Male medicine.medical_specialty Heart disease Population Angiotensin-Converting Enzyme Inhibitors Asymptomatic Diabetes Complications Ventricular Dysfunction Left Enalapril Risk Factors Internal medicine Diabetes mellitus medicine Diabetes Mellitus Odds Ratio Humans Multicenter Studies as Topic cardiovascular diseases Registries education Randomized Controlled Trials as Topic Heart Failure education.field_of_study Ejection fraction business.industry Odds ratio medicine.disease Prognosis Heart failure Cardiology Regression Analysis Female medicine.symptom Cardiology and Cardiovascular Medicine business medicine.drug
Zdroj:	The American journal of cardiology. 77(11)
ISSN:	0002-9149
Popis:	Diabetes is an independent predictor of morbidity and mortality in patients with symptomatic heart failure, patients with asymptomatic left ventricular dysfunction (defined as an ejection fraction of 35% or less), and in a broader registry population with less stringent entry criteria. Although the SOLVD Trials made a major clinical contribution by proving the value of enalapril, diabetes remains a significant predictor of outcome even after adjusting for treatment with enalapril.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c81c6ac3168f39815083348774c713a https://pubmed.ncbi.nlm.nih.gov/8644628 Zobrazit plný text záznamu Full Text from ScienceDirect